Jennifer Jordan and Thomas Suddath, Jr.

Jennifer Jordan is a member of the Global Regulatory Enforcement group at Reed Smith LLP, where she regularly represents clients in sensitive and high-stakes matters across a range of industries. She has extensive experience representing multinational pharmaceutical and life sciences companies in internal and external legal and compliance investigations and related civil and criminal litigation, including matters relating to misbranding, fraud and abuse, anti-kickback, pricing claims and False Claims Act matters. In addition, she has counseled clients on enhancements to compliance programs. Prior to joining Reed Smith, Jennifer served as an Assistant United States Attorney.
Thomas H. Suddath, Jr. is a former federal prosecutor and a partner in the firm’s Global Regulatory Enforcement group in Philadelphia. He has extensive experience counseling clients in the design, implementation and enhancements of corporate compliance programs in the health care sector and other industries. Tom has defended companies in criminal and civil litigation and investigations, including matters involving the False Claims Act, the Foreign Corrupt Practices Act, the Anti-Kickback Statute and the Sherman Act. He also handles national and international internal investigations on behalf of life science companies and energy and natural resource industries.
illustration of hand holding magnifying glass to review documents

The DOJ has issued revisions to its Guidance on evaluating corporate compliance programs while corporations are responding to unprecedented disruption in their businesses. Reed Smith’s Jennifer Jordan and Thomas Suddath, Jr. discuss what companies can reasonably do now to forestall critical review in future investigations. Corporations large and small are trying to turn on a dime to react to new workplace and...

Read more
OneTrust offers download to demonstrate privacy management leadership
Access realtime data
Addressing systemic racism in the workplace SAI Global
Top 10 Risk and Compliance Trends

Special Coverage

Special COVID page graphic